| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54.7M | +22.5% |
| SG&A Expense | $21.8M | +8.2% |
| Operating Income | -$76.5M | -18.1% |
| Income Tax | $0 | — |
| Net Income | -$77.4M | -19.5% |
| EPS (Basic) | -$2.99 | -16.8% |
| EPS (Diluted) | -$2.99 | -16.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.7M | -74.5% |
| Current Assets | $64.6M | -50.0% |
| Total Assets | $145.6M | -27.8% |
| Current Liabilities | $37.2M | +77.4% |
| Long-term Debt | $20.0M | — |
| Total Liabilities | $85.1M | +18.9% |
| Stockholders' Equity | $60.5M | -53.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.7M | -23.8% |
| Capital Expenditures | $19.9M | +108.7% |
| Investing Cash Flow | -$33.0M | -0.8% |
| Financing Cash Flow | $19.7M | -63.3% |
| Free Cash Flow | -$81.6M | -37.5% |